Welcome to LookChem.com Sign In|Join Free
  • or
Tert-butyl (3-bromo-2,6-difluorophenyl)carbamate is a carbamate derivative featuring a tert-butyl group attached to a phenyl ring that is substituted with bromine and fluorine atoms. This chemical compound is characterized by its solid state, high melting point, and low solubility in water, which contribute to its utility in various organic synthesis reactions.

721446-29-3

Post Buying Request

721446-29-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

721446-29-3 Usage

Uses

Used in Pharmaceutical Synthesis:
Tert-butyl (3-bromo-2,6-difluorophenyl)carbamate serves as a reagent in the synthesis of pharmaceuticals, leveraging its unique chemical properties to construct complex molecular structures that can be further utilized in the development of new drugs.
Used in Agrochemical Synthesis:
In the agrochemical industry, tert-butyl (3-bromo-2,6-difluorophenyl)carbamate is employed for the synthesis of compounds that can be used in the development of pesticides and other agricultural chemicals, contributing to the creation of effective solutions for crop protection and enhancement of agricultural productivity.

Check Digit Verification of cas no

The CAS Registry Mumber 721446-29-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,1,4,4 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 721446-29:
(8*7)+(7*2)+(6*1)+(5*4)+(4*4)+(3*6)+(2*2)+(1*9)=143
143 % 10 = 3
So 721446-29-3 is a valid CAS Registry Number.

721446-29-3Relevant academic research and scientific papers

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

-

Page/Page column 51, (2011/04/14)

The invention provides a novel class of compounds of formula 1, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.

Compounds and Compositions as Protein Kinase Inhibitors

-

, (2011/04/14)

The present invention provides compounds of Formula I or II: wherein R1, R1b, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds of Formula (I) or (II) and pharmaceutical compositions thereof are useful for the treatment of B-Raf-associated diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 721446-29-3